<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Rett syndrome: Genetics, clinical features, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Rett syndrome: Genetics, clinical features, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Rett syndrome: Genetics, clinical features, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rebecca J Schultz, PhD, APRN, CPNP-PC, FAES
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Bernhard Suter, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marc C Patterson, MD, FRACP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Helen V Firth, DM, FRCP, FMedSci
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John F Dashe, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 30, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rett syndrome (RTT) is a neurodevelopmental disorder that occurs almost exclusively in females. It was described in 1966 by Andreas Rett, an Austrian pediatrician and neurologist [
         <a href="#rid1">
          1
         </a>
         ]. After a brief period of initially normal development, affected patients experience loss of speech and purposeful hand use, stereotypic hand movements, and gait abnormalities. Additional features include deceleration of head growth, seizures, autistic features, and breathing abnormalities [
         <a href="#rid2">
          2
         </a>
         ]. Most cases result from pathogenic variants in the
         <em>
          MECP2
         </em>
         gene [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         This topic will review the genetics, clinical features, and diagnosis of Rett syndrome. The treatment and prognosis are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/109840.html" rel="external">
          "Rett syndrome: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
         Autism spectrum disorders are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/595.html" rel="external">
          "Autism spectrum disorder (ASD) in children and adolescents: Terminology, epidemiology, and pathogenesis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/627.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Clinical features"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/628.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Evaluation and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H702219213">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Genetics
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the majority of patients, RTT is caused by pathogenic variants in the
         <em>
          MECP2
         </em>
         gene, which maps to Xq28 and encodes methyl-CpG binding protein 2 (MeCP2) [
         <a href="#rid3">
          3
         </a>
         ]. Although MeCP2 is expressed in all tissues, it is most abundant in the brain, which may be more sensitive to abnormal MeCP2 than other tissues. Pathogenic variants in
         <em>
          MECP2
         </em>
         have been detected in approximately 95 percent of classic sporadic RTT cases and 75 percent of atypical RTT cases [
         <a href="#rid4">
          4,5
         </a>
         ]. A minority of patients have atypical RTT caused by pathogenic variants in the
         <em>
          CDKL5
         </em>
         or
         <em>
          FOXG1
         </em>
         genes, though aberrations in these genes most often cause neurodevelopmental phenotypes that are now recognized as separate disorders [
         <a href="#rid6">
          6,7
         </a>
         ]. (See
         <a class="local">
          'Classification and major features'
         </a>
         below and
         <a class="local">
          'Atypical RTT'
         </a>
         below.)
        </p>
        <p>
         There are three types of pathogenic variants in
         <em>
          MECP2
         </em>
         : missense, frameshift, and nonsense. The type of mutation may affect phenotypic expression. (See
         <a class="local">
          'Genotype-phenotype correlations'
         </a>
         below.)
        </p>
        <p>
         Rett syndrome is sporadic in nearly all cases (&gt;99 percent) and is most often due to de novo mutations in the
         <em>
          MECP2
         </em>
         gene [
         <a href="#rid8">
          8
         </a>
         ]. These mutations are almost exclusively of paternal origin [
         <a href="#rid9">
          9
         </a>
         ]. This may explain the high female to male ratio in RTT and suggests another cause of (apparent) male sparing besides early lethality. In rare hereditary cases, the mother was either a carrier of the pathogenic variant [
         <a href="#rid3">
          3,10-14
         </a>
         ] or a mosaic for the variant [
         <a href="#rid3">
          3
         </a>
         ]. In one family with affected male children and a female child with classic RTT, the
         <em>
          MECP2
         </em>
         variant was located on the mother's paternal X-chromosome [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         Most individuals with RTT have random X-inactivation (also known as Lyonization) so that the normal
         <em>
          MECP2
         </em>
         allele is expressed in some cells [
         <a href="#rid3">
          3,15
         </a>
         ]. The normal allele appears to enable affected females to survive but does not protect them from neurodevelopmental abnormalities [
         <a href="#rid3">
          3
         </a>
         ]. Random inactivation also contributes to the spectrum of phenotypes in RTT. Except in special circumstances such as Klinefelter syndrome or mosaicism, similar pathogenic variants in brothers of affected females most often result in severe neonatal encephalopathy and are lethal.
        </p>
        <p>
         Some affected patients have nonrandom X-inactivation. In one series, this was associated with a milder phenotype or a mitigated classic RTT caused by a rare, early truncating mutation [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Pathogenic variants in the
         <em>
          MECP2
         </em>
         gene have also been detected in other neurologic disorders. These include females with non-Rett phenotypes such as autism, females and males with nonspecific X-linked intellectual disability, and males with progressive spasticity, congenital encephalopathy with respiratory arrest, or non-fatal neurodevelopmental disorders [
         <a href="#rid11">
          11-13,16,17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/627.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Clinical features", section on 'Terminology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/595.html" rel="external">
          "Autism spectrum disorder (ASD) in children and adolescents: Terminology, epidemiology, and pathogenesis", section on 'Genetic factors'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Mechanism
         </span>
         <span class="headingEndMark">
          —
         </span>
         How pathogenic variants in
         <em>
          MECP2
         </em>
         lead to RTT is not fully established. The leading hypothesis is that MeCP2 deficiency leads to failure of synaptic maturation and maintenance in the cortex [
         <a href="#rid18">
          18-20
         </a>
         ].
         <em>
          MECP2
         </em>
         contains two functional domains, a methyl-CpG binding domain and a transcriptional repression domain [
         <a href="#rid21">
          21
         </a>
         ]. MeCP2 is considered a high-level genome-wide regulator with a variety of putative functions, which include transcriptional repression and activation, modulation of transcription and retrotransposition of long interspersed nuclear elements-1 (L1s) in neurons, and promotion of gene imprinting [
         <a href="#rid18">
          18,22
         </a>
         ]. Thus, it is likely that MeCP2 deficiency or loss of function causes aberrant expression of its different target genes during and after neuronal development, which results in RTT.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Genotype-phenotype correlations
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are more than 250 known pathogenic variants in
         <em>
          MECP2
         </em>
         associated with RTT [
         <a href="#rid23">
          23
         </a>
         ]. However, nearly 80 percent of cases are comprised of the eight most frequently identified point mutations (R106W, R133C, T158M, R168X, R255X, R270X, R294X, R306C) and C-terminal truncations.
        </p>
        <p>
         Studies evaluating large databases or series of patients with RTT and animal models suggest that the R133C, R294X, and C-terminal truncating mutations are associated with somewhat milder disease, while the R168X, R255X, R270X, and T158M mutations are associated with more severe disease [
         <a href="#rid5">
          5,24-29
         </a>
         ].
        </p>
        <p>
         There is evidence that truncating mutations occurring before and including amino acid R270X may cause a more severe phenotype [
         <a href="#rid30">
          30,31
         </a>
         ]. Although these phenotypic differences can be distinguished among RTT populations, pathogenic variants in
         <em>
          MECP2
         </em>
         have broadly overlapping phenotypic variability. While their prognostic value for individual patients with RTT is limited, these data may serve as a general guide to phenotype severity [
         <a href="#rid28">
          28,32
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Neuropathology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Brain growth is differentially affected in RTT. In a postmortem study of 39 patients 3 to 35 years old, most RTT brains were smaller than normal and did not grow after age four years [
         <a href="#rid33">
          33
         </a>
         ]. By contrast, the heart, kidneys, liver, and spleen grew at a normal rate until 8 to 12 years of age. At that time, their growth rate decelerated but continued so that organ weights were appropriate for height, which was also reduced. Adrenal organ weights were normal.
        </p>
        <p>
         Deceleration of brain growth in RTT begins after birth. The mechanism is uncertain but appears to reflect arrested development. This is supported by morphologic observations that include no evidence of brain degeneration, no alteration in brain weight with increasing age, lack of correlation of dendritic length with increasing age, and reduced neuromelanin in the substantia nigra [
         <a href="#rid34">
          34-39
         </a>
         ].
        </p>
        <p>
         In one study, the dendrites of pyramidal neurons were examined in six regions of the cerebral cortex in females with RTT, ages 2.9 to 35 years [
         <a href="#rid40">
          40
         </a>
         ]. The cortex was selectively involved. The apical and basilar dendritic branches in layers 3 and 5 of the frontal, motor, and inferior temporal cortex were shorter compared with brains in trisomy 21 or non-Rett neurologic disorders. These findings did not change with age.
        </p>
        <p>
         In other reports, the proteins that initiate cortical dendritic differentiation and expansion (Map2, adult form) and dendritic remodeling (cyclooxygenase) were reduced in RTT [
         <a href="#rid41">
          41,42
         </a>
         ]. This indicated marked disruption of a major cytoskeletal component in the cortex. The relationship of these findings with
         <em>
          MECP2
         </em>
         variants is unknown.
        </p>
        <p class="headingAnchor" id="H33403553">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         RTT is a rare disorder that occurs mainly in females. In a report from a large population-based registry in Texas, the prevalence of classic RTT was estimated as 1 per 22,800 females ages 2 through 18 years, or 0.44 per 10,000 [
         <a href="#rid43">
          43
         </a>
         ]. The prevalence per 10,000 females was 0.56 in France [
         <a href="#rid44">
          44
         </a>
         ], 0.65 in Sweden and Scotland [
         <a href="#rid45">
          45,46
         </a>
         ], and 0.72 in Australia [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
         RTT occurs in all ethnic and racial groups, and at similar rates [
         <a href="#rid43">
          43,48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          CLASSIFICATION AND MAJOR FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         RTT is not a degenerative disorder. Rather, it is a progressive disorder with multisystem symptom evolution over the lifespan [
         <a href="#rid49">
          49
         </a>
         ]. The clinical phenotype of RTT is broad and is divided into two main categories [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Typical (classic) RTT
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Atypical (variant) RTT
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2830321633">
         <span class="h2">
          Typical RTT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical picture of typical (classic) RTT is unique. Affected patients initially develop normally and then experience loss of speech and purposeful hand use and onset of stereotypic hand movement and gait abnormalities. Additional manifestations can include deceleration of head growth, seizures, autistic features, intermittent breathing abnormalities, autonomic nervous system dysfunction, cardiac abnormalities, and sleep disturbances.
        </p>
        <p>
         Females with classic RTT are typically born at term after an uneventful pregnancy and delivery. They usually appear developmentally normal for the first six months with no gross abnormalities  (
         <a class="graphic graphic_picture graphicRef53558" href="/z/d/graphic/53558.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef76864" href="/z/d/graphic/76864.html" rel="external">
          picture 2
         </a>
         ). Although some nonspecific signs may be present during the first six months [
         <a href="#rid50">
          50,51
         </a>
         ], no clinically significant developmental problems typically appear during that time other than deceleration of head growth.
        </p>
        <p>
         Deceleration of head growth beginning as early as two to three months of age is often the first sign of RTT, although this feature is not present in all individuals with typical RTT [
         <a href="#rid52">
          52
         </a>
         ] and is no longer considered one of the necessary criteria for RTT [
         <a href="#rid2">
          2
         </a>
         ]. At 12 to 18 months, loss of acquired fine motor, intellectual, and communicative abilities is seen  (
         <a class="graphic graphic_picture graphicRef65333" href="/z/d/graphic/65333.html" rel="external">
          picture 3
         </a>
         and
         <a class="graphic graphic_picture graphicRef56128" href="/z/d/graphic/56128.html" rel="external">
          picture 4
         </a>
         ) [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         In some cases, this regression is rapid, with parents or caregivers reporting "She woke up and was no longer speaking." More often, regression is slow and insidious, occurring over weeks to months with diminished interest in the surroundings and loss of purposeful hand use. During this phase, unprovoked episodes of inconsolable screaming may occur during the day or at night, disrupting sleep. These begin abruptly, may last for hours, and often provoke an exhaustive evaluation for other medical conditions if RTT has not yet been diagnosed.
        </p>
        <p>
         In the beginning of the regression phase, stereotypic hand movements may be subtle and interspersed with purposeful hand use. They typically consist of periodic hand-to-mouth licking or grasping of the hair or clothing. Each individual develops her own distinctive unique hand pattern  (
         <a class="graphic graphic_picture graphicRef67899" href="/z/d/graphic/67899.html" rel="external">
          picture 5
         </a>
         ). Some retain the ability to hold a cup or feed themselves in a messy, rudimentary manner.
        </p>
        <p>
         Following the regression phase, there is a period of stabilization and some recovery of nonverbal communication, with improved eye contact and nonverbal interactions with the environment. This is later followed by a slow, insidious deterioration in gross motor function, often becoming noticeable in teenage years.
        </p>
        <p class="headingAnchor" id="H1217387243">
         <span class="h2">
          Atypical RTT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atypical RTT is the term used for variants of RTT that have many but not all of the clinical features of typical RTT. Importantly, these variants are also characterized by a phase of regression in skills in infancy or childhood [
         <a href="#rid2">
          2
         </a>
         ]. Historically, there were three defined atypical forms of RTT [
         <a href="#rid2">
          2,54
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preserved speech
         </strong>
         – The preserved speech variant (or Zappella variant) of RTT is a less severe form of the syndrome that is characterized by recovery of language after regression, with most girls able to speak in sentences, and generally milder expression of typical RTT features [
         <a href="#rid55">
          55,56
         </a>
         ]. The majority of patients with this variant have pathogenic variants in
         <em>
          MECP2
         </em>
         [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Early onset seizures
         </strong>
         – The early-onset seizure variant (or Hanefeld variant) of RTT is caused by pathogenic variants in the
         <em>
          CDKL5
         </em>
         gene and is characterized by a Rett-like picture with the onset of epilepsy between the first week and fifth month of life as a significant feature [
         <a href="#rid57">
          57-61
         </a>
         ]. However, most pathogenic variants in
         <em>
          CDKL5
         </em>
         are now recognized to lead to a distinct condition known as CDKL5 deficiency disorder and classified as a developmental epileptic encephalopathy [
         <a href="#rid62">
          62
         </a>
         ]. Some cases of the early-seizure variant may also be caused by pathogenic variants in
         <em>
          CACNA1A
         </em>
         [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital
         </strong>
         – The congenital variant (or Rolando variant) of RTT caused by pathogenic variants in the
         <em>
          FOXG1
         </em>
         gene [
         <a href="#rid64">
          64-66
         </a>
         ] is distinct from RTT due to
         <em>
          MECP2
         </em>
         variants by onset within the first six months of life.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1466388415">
         <span class="h2">
          Males with MECP2 variants
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical phenotype of males with pathologic variants in
         <em>
          MECP2
         </em>
         includes severe neonatal encephalopathy associated with early death, atypical RTT, classic Rett syndrome, and cognitive impairment [
         <a href="#rid67">
          67
         </a>
         ] The assumption that
         <em>
          MECP2
         </em>
         pathogenic variants in males always causes embryonic lethality or early postnatal demise is incorrect.
        </p>
        <p>
         A 2019 report examined the experience of the Rett Syndrome Natural History study, which enrolled over 1200 individuals with RTT, or with
         <em>
          MECP2
         </em>
         variants [
         <a href="#rid67">
          67
         </a>
         ]. The report identified 30 males (age at diagnosis 0.6 to 20.4 years) with
         <em>
          MECP2
         </em>
         variants that spanned the entire gene, of which 27 were considered pathogenic variants. Among the 30 males, phenotypes included:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Atypical RTT in 14 (47 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cognitive impairment or progressive encephalopathy in 10 (33 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neonatal encephalopathy in 4 (13 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Classic RTT in 2 (7 percent)
        </p>
        <p>
        </p>
        <p>
         Nine males had died (age at death 3.2 to 29.8 years) and 21 were alive at the time of the report [
         <a href="#rid67">
          67
         </a>
         ]. Compared with females with RTT, the 14 males meeting criteria for atypical RTT had a more severe clinical presentation and course, but their clinical manifestations were less characteristic of RTT; none had eye pointing, and the presence of other RTT features, such as loss of spoken language, loss of hand skills, or hand stereotypies, was variable. The investigators proposed the term "male RTT encephalopathy" as a diagnostic category for males who have a clearly identified pattern of regression, fulfill criteria for atypical RTT by meeting at least two of the four main criteria and at least five of eleven supportive criteria for RTT (see
         <a class="local">
          'Clinical diagnostic criteria'
         </a>
         below), and have pathogenic variant in
         <em>
          MECP2
         </em>
         .
        </p>
        <p>
         A 2015 systematic review identified 36 studies describing 57 cases of RTT in males [
         <a href="#rid68">
          68
         </a>
         ]. The cases had either a confirmatory diagnosis of RTT or clinical features consistent with typical or atypical RTT. The average age was 7.7 years, and the most common symptoms were abnormal gait/trunk movements, partial or complete loss of spoken language, head growth deceleration, and epilepsy. However, pathogenic variants in
         <em>
          MECP2
         </em>
         were reported in only 65 percent of cases.
        </p>
        <p class="headingAnchor" id="H3807189153">
         <span class="h1">
          TYPICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Manifestations of RTT typically include loss of purposeful hand skills, gait and motor abnormalities, loss of spoken language, and stereotypic hand movements. (See
         <a class="local">
          'Classification and major features'
         </a>
         above.)
        </p>
        <p>
         Additional features of RTT include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Growth failure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epilepsy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disorganized breathing pattern during wakefulness characterized by periods of apnea alternating with periods of hyperventilation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bone mineral deficit and fractures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autonomic nervous system dysfunction, characterized by cold feet and peripheral vasomotor disturbances
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiac abnormalities
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sleep disturbances
        </p>
        <p>
        </p>
        <p>
         These are reviewed in the sections that follow.
        </p>
        <p class="headingAnchor" id="H107356647">
         <span class="h2">
          Loss of spoken language
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of females with RTT lose expressive language during early childhood, although some may retain one-word expressions. They appear to communicate via eye gaze, body language, and facial expressions. However, it is often difficult to measure these behaviors using standardized instruments. A systematic review of eight studies that included 41 females with RTT (age 2 to 36 years) found some evidence of communicative behaviors for at least some individuals in each included study [
         <a href="#rid69">
          69
         </a>
         ]. The authors concluded that the validity of these findings is unknown, in part because of the lack of valid measuring tools to assess communication in individuals with impairments as severe as those found with RTT.
        </p>
        <p class="headingAnchor" id="H107358573">
         <span class="h2">
          Motor dysfunction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Extrapyramidal motor dysfunction with stereotypic hand movements and gait disturbance affects all patients with RTT. Stereotypic hand movements include opposition of hands, finger kneading and rubbing, hand clapping and washing, wringing, squeezing, twisting, and pill rolling  (
         <a class="graphic graphic_picture graphicRef67899" href="/z/d/graphic/67899.html" rel="external">
          picture 5
         </a>
         ) [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         The gait typically is broad-based, clumsy, and ataxic/apraxic [
         <a href="#rid1">
          1,53
         </a>
         ]. Patients often have retropulsion and rock to and fro while standing or sitting. Many have difficulty crossing from one floor surface or color to another and will stop and refuse to take another step.
        </p>
        <p>
         Extrapyramidal motor disturbances were characterized in a series of 32 affected patients, ages 30 months to 28 years [
         <a href="#rid71">
          71
         </a>
         ]. Abnormalities identified in addition to stereotypic movements and gait disturbance included:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bruxism – 97 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Excessive drooling – 75 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oculogyric crises – 63 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypomimia – 63 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dystonia – 59 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rigidity – 44 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bradykinesia – 41 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Proximal myoclonus – 34 percent
        </p>
        <p>
        </p>
        <p>
         The underlying mechanism for these extrapyramidal disturbances is not known.
        </p>
        <p class="headingAnchor" id="H107358580">
         <span class="h2">
          Scoliosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Scoliosis is common in RTT and increases with age. By age 16, the prevalence of scoliosis in patients with RTT ranges from 50 to 85 percent [
         <a href="#rid72">
          72,73
         </a>
         ].
        </p>
        <p>
         Factors that are associated with an increased risk of developing scoliosis include inability to sit or walk unaided, lack of purposeful hand use, lack of breath holding, onset of puberty, and higher clinical severity scores [
         <a href="#rid72">
          72,73
         </a>
         ].
        </p>
        <p>
         In addition, the risk for developing scoliosis varies with genotype [
         <a href="#rid72">
          72,73
         </a>
         ]. In an analysis of a large RTT database, the risk of scoliosis (after adjusting for age) was significantly increased for those with severe mutations (
         <em>
          R106W
         </em>
         ,
         <em>
          R168X
         </em>
         ,
         <em>
          R255X
         </em>
         ,
         <em>
          R270X
         </em>
         ) and large deletions [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H27884434">
         <span class="h2">
          Growth failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         The characteristic growth pattern of RTT consists of early deceleration of head growth, followed by deceleration of weight and height measurements [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         This pattern of head growth deviates from growth aberrations associated with chronic disease or central nervous system or chromosomal disorders while the deceleration in ponderal growth is similar to patterns seen with acute and chronic malnutrition. Deceleration in head growth may provide the earliest clinical indicator for the diagnosis of RTT but is not required for the clinical diagnosis.
        </p>
        <p>
         In a longitudinal study of growth in 816 females with RTT, including 726 with typical (classic) RTT and 90 with atypical RTT, the following observations were noted for growth in typical RTT [
         <a href="#rid74">
          74
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mean head circumference decreased below that of the normative population at one month (see
         <a class="medical medical_review" href="/z/d/html/2845.html" rel="external">
          "Normal growth patterns in infants and prepubertal children", section on 'Evaluation of growth'
         </a>
         ). By age two years, mean head circumference was two standard deviations below normal.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mean weight fell below normal by age 13 months and declined to the second percentile at age 12.5 years.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mean height decreased below normal by age 17 months and was two standard deviations below normal by age 12 years. However, the distribution of height in classic RTT was wide, and height above the 98
         <sup>
          th
         </sup>
         percentile was observed in approximately 8 percent of girls with RTT.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pubertal increases in height and weight were attenuated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Poor growth was associated with greater disease severity.
        </p>
        <p>
        </p>
        <p>
         Five patterns of growth were discerned in typical RTT [
         <a href="#rid74">
          74
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe somatic growth failure with microcephaly (33 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal somatic growth with microcephaly (30 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Moderate somatic growth failure with microcephaly (19 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal growth (14 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Moderate somatic growth failure with normal head size (3 percent)
        </p>
        <p>
        </p>
        <p>
         Compared with typical RTT, a greater proportion of patients with atypical RTT had normal growth [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         In another study, individuals with RTT had slower rates of hand and foot growth than normal [
         <a href="#rid75">
          75
         </a>
         ]. Relative to height, the rate of decelerated growth was greater for feet than hands.
        </p>
        <p class="headingAnchor" id="H27884441">
         <span class="h3">
          Nutrition
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although multiple factors are likely responsible for the growth aberration in RTT, inadequate nutrition appears to play an important role. This may result from inadequate dietary intake, alterations in energy expenditure, and/or feeding difficulties [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         The contribution of increased energy expenditure due to involuntary repetitive movements is uncertain. In one study, total daily energy expenditure adjusted for differences in body weight was similar in RTT and controls [
         <a href="#rid77">
          77
         </a>
         ]. In another study from the same group, metabolic rates while sleeping and quietly awake were 23 percent lower in patients with RTT than controls; rates while actively awake were similar [
         <a href="#rid78">
          78
         </a>
         ]. Although total daily energy expenditure was similar in the two groups, energy balance was less positive in the individuals with RTT than controls. If sustained, these small deficits in energy balance may account for growth failure. In another preliminary report, rates of amino acid loss were significantly greater in patients with RTT than controls, indicating failure to suppress endogenous body protein degradation [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H27884448">
         <span class="h3">
          Feeding impairment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Feeding impairment, characterized as chewing or swallowing difficulties, choking, and nasal regurgitation, frequently complicates RTT [
         <a href="#rid80">
          80-86
         </a>
         ]. In addition to oromotor dysfunction, the upper gastrointestinal tract may be affected. In a study of 34 females with RTT ages 2 to 40 years, oropharyngeal dysfunction and upper gastrointestinal dysmotility occurred in 95 and 68 percent, respectively [
         <a href="#rid87">
          87
         </a>
         ]. Abnormalities of oropharyngeal function included poor tongue mobility, reduced oropharyngeal clearance, and laryngeal penetration of liquids and solid foods during swallowing. Esophageal dysmotility, characterized by the absence of primary or secondary waves, delayed emptying, atony, the presence of tertiary waves, or spasm was found in 11 patients (39 percent). Gastroesophageal reflux was present in 11 patients (35 percent), including one with nasopharyngeal reflux. Six patients (20 percent) had gastric dysmotility, characterized as decreased peristalsis or atony, and one had duodenal dysmotility.
        </p>
        <p>
         In another study, decreased dietary energy intake was associated with poor chewing and persistence of liquid and solid food residue in the pyriform sinuses and valleculae, as well as decreased body fat [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H33395658">
         <span class="h2">
          Epilepsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Seizures occur in the majority of patients with RTT [
         <a href="#rid88">
          88,89
         </a>
         ]. A large study from the Rare Disease Network for Rett syndrome including 528 patients (ages 8 months to 64 years) who met classic criteria for RTT reported the following [
         <a href="#rid90">
          90
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Parent-reported seizures affected 360 patients (60 percent), and the frequency was similar for patients with classic and atypical RTT. By physician assessment of the clinical description of seizures, epileptic seizures affected 291 patients (48 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The prevalence of epilepsy increased with age. Seizures were not reported before age two years, but thereafter the proportion affected by seizures was as follows:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         2 to &lt;5 years, approximately 33 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         5 to &lt;10 years, 60 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         10 to &lt;15 years, 77 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         15 to &lt;30 years, 84 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ≥30 years old, 86 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond age 30, there was no increase in proportion with epilepsy, suggesting that late onset of seizures in adults with RTT is unlikely.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with RTT who are affected by epilepsy, the seizure frequency varied widely, with no seizures for six months prior to evaluation in 36 percent, monthly seizures in 27 percent, weekly seizures in 20 percent, and daily seizures in 11 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After adjustment for age, the occurrence of seizures was associated with higher scores for clinical severity of RTT.
        </p>
        <p>
        </p>
        <p>
         Other smaller studies have reported a higher prevalence of seizures in RTT. As an example, a series from Sweden reported that epilepsy affected 50 of 53 patients with RTT (94 percent) [
         <a href="#rid91">
          91
         </a>
         ]. Two of the nine deaths that occurred were associated with seizures (aspiration and status epilepticus). Patients had all seizure types except for typical absence and clonic seizures. The most common were complex partial, tonic-clonic, tonic, and myoclonic seizures. In this series, intractable (medically refractory) epilepsy was observed in approximately one-half of the patients.
        </p>
        <p>
         The occurrence of epilepsy in RTT may be overestimated because affected patients have a variety of abnormal behaviors that can be mistaken as seizure manifestations [
         <a href="#rid88">
          88,92,93
         </a>
         ]. These include breath holding, hyperventilation, incessant hand wringing, "vacant" episodes with sudden-absence-like freezing of activity, inappropriate screaming or laughter, and motor abnormalities (dystonia, tremulousness, and limpness). However, these events do not have associated electroencephalogram (EEG) changes. This point was illustrated by a study of video/polygraphic/EEG monitoring in 82 females with RTT ages 2 to 30 years, all of whom had epileptiform abnormalities on EEG [
         <a href="#rid94">
          94
         </a>
         ]. During monitoring, 51 percent of the parents identified events that they thought represented their child's typical seizure, such as twitching, jerking, head turning, falling forward, and trembling, as well as episodes of staring, laughing, pupil dilatation, breath holding, and hyperventilation. However, only 18 percent of these clinical episodes correlated with an EEG seizure discharge. In addition, some electrographic seizures were unrecognized by parents or occurred during sleep.
        </p>
        <p class="headingAnchor" id="H27884455">
         <span class="h2">
          Bone mineral deficit and fractures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bone density frequently appears diminished on conventional radiographs in females with RTT, although the cause is unknown. This is seen in affected children (age two to five years) and adults, whether or not they are ambulatory. Females with RTT have abnormally low regional bone mineral density and whole-body bone mineral content [
         <a href="#rid95">
          95-97
         </a>
         ]. In one study, bone mineral content was measured by dual-energy x-ray absorptiometry in 106 females with various diseases, including RTT, cystic fibrosis, juvenile dermatomyositis, liver disease, and human immunodeficiency virus (HIV) [
         <a href="#rid98">
          98
         </a>
         ]. Bone mineral deficit was greatest in the patients with RTT, who all had severe abnormalities.
        </p>
        <p>
         Individuals with RTT have a nearly fourfold increased risk of bone fracture when compared with the general population [
         <a href="#rid99">
          99,100
         </a>
         ]. The risk appears to be associated with the presence of decreased bone thickness, more severe disease variants, and the use of antiepileptic medications.
        </p>
        <p class="headingAnchor" id="H27884469">
         <span class="h2">
          Cardiac abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         The annual incidence of sudden unexpected death is higher in RTT than in the general population (0.3 percent, versus 0.0001 percent for people ages 1 to 22 years) [
         <a href="#rid101">
          101-103
         </a>
         ]. The mechanism is thought to be cardiac electrical instability due to abnormal autonomic nervous system regulation [
         <a href="#rid104">
          104
         </a>
         ]. Increased sympathetic activity (see
         <a class="local">
          'Autonomic dysfunction'
         </a>
         below) is suggested by the increased incidence of prolonged rate-corrected QT interval (QTc) in RTT. In several reports, the incidence of prolonged QTc (&gt;0.45 msec) was higher and heart rate variability was lower in girls with RTT than age-matched controls [
         <a href="#rid102">
          102,105-107
         </a>
         ]. An increased proportion of QTc interval prolongation with advancing RTT clinical stage has been shown by some studies [
         <a href="#rid102">
          102,105
         </a>
         ] but not by others [
         <a href="#rid106">
          106,107
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1036.html" rel="external">
          "Congenital long QT syndrome: Epidemiology and clinical manifestations"
         </a>
         .)
        </p>
        <p>
         Abnormal autonomic regulation is also suggested by a study of cardiac vagal tone, cardiac response to baroreflex, and beat-to-beat heart rate measured during rest, hyperventilation, and immediately after hyperventilation [
         <a href="#rid108">
          108
         </a>
         ], and by a report demonstrating an uncoupling of breathing and heart rate control in girls with RTT [
         <a href="#rid109">
          109
         </a>
         ] The authors of the latter study suggested that this uncoupling may represent a mechanism that increases vulnerability to sudden death in RTT. A deficiency in substance P in the central nervous system identified in girls with RTT may contribute to impairment of autonomic nervous system dysfunction, resulting in cardiac dysautonomia [
         <a href="#rid110">
          110,111
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4046451811">
         <span class="h2">
          Autonomic dysfunction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 50 to 70 percent of patients with RTT have clinical features that indicate autonomic nervous system dysfunction with increased sympathetic tone and impaired parasympathetic response [
         <a href="#rid112">
          112-114
         </a>
         ]. In addition to cardiac abnormalities and lack of heart rate variability (see
         <a class="local">
          'Cardiac abnormalities'
         </a>
         above), these include color and temperature abnormalities of the extremities (eg, the presence of cold, blue feet or hands), drooling, breathing irregularities (see
         <a class="local">
          'Disorders of respiratory control'
         </a>
         below), sweating abnormalities, episodes of pupillary dilatation, and possibly gut dysmotility.
        </p>
        <p class="headingAnchor" id="H27884490">
         <span class="h2">
          Disorders of respiratory control
         </span>
         <span class="headingEndMark">
          —
         </span>
         A characteristic pattern of disordered breathing during wakefulness occurs in 60 to 80 percent of patients with RTT [
         <a href="#rid115">
          115-120
         </a>
         ]. This pattern consists of episodes of hyperventilation with concomitant hypocapnia alternating with hypoventilation and/or apnea. The periods of hypoventilation and/or apnea may last as long as 20 to 120 seconds and result in hypoxemia. Breathing usually is normal between these episodes. In an analysis of a large RTT database, breathing dysfunction was associated with pathogenic variants in
         <em>
          MECP2
         </em>
         and clinical RTT, low body mass index Z-scores, frequency of hand stereotypies, and higher Global Clinical Severity Scores [
         <a href="#rid120">
          120
         </a>
         ]. Moreover, a prolonged QTc interval was associated with severe breathing dysfunction.
        </p>
        <p>
         Episodes of hyperventilation tend to occur when the child is excited or agitated and are frequently associated with other stereotypic movements. Apnea that occurs during wakefulness is typically central, although it may be obstructive. These events may be isolated or precede or follow hyperventilation. During apneic episodes, the child may stare quietly ahead or smile and appear happy with no evidence of distress, despite severe cyanosis.
        </p>
        <p>
         Breathing abnormalities may cause severe hypoxemia [
         <a href="#rid117">
          117
         </a>
         ]. In studies recording EEG and breathing in our laboratory, hypoxemia led to electrographic seizures only when it was associated with apnea. Seizures did not occur with disorganized breathing alone, even when oxygen saturation was as low as 30 to 50 percent. The breathing abnormalities during the awake state are not associated with bradycardia [
         <a href="#rid118">
          118
         </a>
         ]. However, these events are frequently misdiagnosed as seizures. The EEG correlate may be characterized by diffuse, high amplitude slowing, a hyperventilatory response that can be mistaken for ictal electrographic changes. The EEG changes depend on severity of the episodes.
        </p>
        <p>
         The underlying pathophysiology of disordered breathing and its relationship to the
         <em>
          MECP2
         </em>
         mutation are not well-understood, but may be related to defective neuromodulation and synaptic transmission in the brainstem respiratory centers [
         <a href="#rid121">
          121,122
         </a>
         ].
        </p>
        <p>
         Breathing disturbances in patients with RTT are more pronounced during wakefulness but can also occur during sleep, including apnea, shallow breathing, hypoventilation, and increased periodic breathing [
         <a href="#rid109">
          109,116,118,123
         </a>
         ].
        </p>
        <p>
         Although data are limited, one small study using high resolution computed tomography (CT) imaging found pulmonary lesions suggestive of interstitial lung disease in approximately one-half of patients with RTT and respiratory dysfunction [
         <a href="#rid124">
          124
         </a>
         ]. The pathogenesis and clinical significance of these pulmonary abnormalities is uncertain.
        </p>
        <p class="headingAnchor" id="H27884497">
         <span class="h2">
          Sleep disturbance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sleep disturbances affect 80 percent or more of patients with RTT, and are a problem for both the patient and caregivers [
         <a href="#rid125">
          125,126
         </a>
         ]. The symptoms most commonly reported by caregivers are irregular sleep times, including prolonged periods of wakefulness or sleep, periodic nighttime awakenings with disruptive behavior (such as crying, screaming, laughing), and abbreviated total nighttime sleep with increased amounts of daytime sleep.
        </p>
        <p>
         Sleep architecture is abnormal in RTT. In one report, the amount of rapid eye movement (REM) sleep was less than age-matched healthy controls [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H522064042">
         <span class="h2">
          Others
         </span>
         <span class="headingEndMark">
          —
         </span>
         Constipation, urinary incontinence, and fecal incontinence appear to be common problems in females with RTT [
         <a href="#rid127">
          127
         </a>
         ]. One study of 63 females with RTT (mean age 19 years) reported that urinary incontinence affected &gt;95 percent and fecal incontinence affected a majority [
         <a href="#rid128">
          128
         </a>
         ].
        </p>
        <p>
         Findings from another small study suggest that gallbladder dysfunction and gallstones are more frequent in RTT compared with the general population [
         <a href="#rid129">
          129
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1380209388">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical evaluation for suspected RTT includes the history, examination, and genetic testing. In some cases, additional studies may be helpful.
        </p>
        <p class="headingAnchor" id="H4235332161">
         <span class="h2">
          History and examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         A thorough history should be obtained from the parents and caregivers. Special attention should be paid to the timing of developmental milestones and the presence of a period of regression with loss of hand skills and spoken language.
        </p>
        <p>
         Physical examination should identify the characteristic findings of RTT. Measurements typically show impaired growth. Serial measurements often show decelerating head growth, and ultimately microcephaly. A variety of neurologic manifestations may be seen, including intellectual disability or developmental delay, loss of or poor communication skills, and stereotypic hand movements. (See
         <a class="medical medical_review" href="/z/d/html/6172.html" rel="external">
          "Intellectual disability (ID) in children: Clinical features, evaluation, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H589885988">
         <span class="h2">
          DNA analysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         A clinical diagnosis of typical or atypical Rett syndrome should not be made without specialist evaluation including comprehensive genetic testing. A blood sample should be obtained for DNA analysis to identify pathogenic variants in
         <em>
          MECP2
         </em>
         in a female with characteristic signs of RTT. Testing should also be considered in male infants with severe encephalopathy. The diagnosis of RTT (
         <em>
          MECP2
         </em>
         positive) is made if a pathogenic variant in
         <em>
          MECP2
         </em>
         is found and clinical criteria are met.
        </p>
        <p>
         For those who have a negative analysis for known pathogenic variants in
         <em>
          MECP2
         </em>
         , further genetic testing should include analysis for variants in
         <em>
          FOXG1
         </em>
         (if features of the congenital variant are present) and
         <em>
          CDKL5
         </em>
         (if features of the early seizure variant are present) [
         <a href="#rid2">
          2
         </a>
         ]. A comprehensive genetic evaluation is recommended if a pathogenic variant is not detected in
         <em>
          MECP2
         </em>
         ,
         <em>
          CDKL5
         </em>
         , or
         <em>
          FOXG1
         </em>
         [
         <a href="#rid130">
          130,131
         </a>
         ]. Whole exome sequencing can identify variants in other genes that lead to the development of phenotypes resembling RTT [
         <a href="#rid132">
          132
         </a>
         ]. Thus, in cases where the known variants are not detected, we perform whole exome sequencing; specialized genetic panels may be available such as a Rett panel. Methods of genetic testing are evolving. (See
         <a class="medical medical_review" href="/z/d/html/17039.html" rel="external">
          "Next-generation DNA sequencing (NGS): Principles and clinical applications"
         </a>
         .)
        </p>
        <p>
         Girls presenting with developmental problems of unknown etiology warrant genetic investigation and consideration of
         <em>
          MECP2
         </em>
         testing if they have some features suggestive of RTT. This situation is most likely to arise for individuals &lt;3 years old.
        </p>
        <p>
         DNA analysis should be offered to the mother if future pregnancies are planned. Prenatal testing is available. Male siblings with neurologic or developmental disorders should also be tested. Female siblings may choose to have testing done when they reach an age at which they are able to give informed consent.
        </p>
        <p class="headingAnchor" id="H2752684507">
         <span class="h2">
          Other studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a child with developmental delay where no relevant pathogenic variant is identified in
         <em>
          MECP2
         </em>
         ,
         <em>
          CDKL5
         </em>
         , or
         <em>
          FOXG1
         </em>
         , inborn errors of metabolism and neurodegenerative disorders should be considered as part of the general evaluation of(see
         <a class="local">
          'Differential diagnosis'
         </a>
         below). Suggested studies to exclude these disorders include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brain magnetic resonance imaging (MRI)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum amino acids
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urine organic acids
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Genetic testing for Rett-like phenotypes, including Angelman and Angelman-like syndromes and/or Pitt-Hopkins syndrome if clinically suspected (see
         <a class="local">
          'Differential diagnosis'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         White cell enzymes (if regression)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hearing test
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ophthalmologic evaluation
        </p>
        <p>
        </p>
        <p>
         The patient could be considered to have RTT without an
         <em>
          MECP2
         </em>
         variant if these studies are nondiagnostic, clinical criteria for RTT are met, and genetic analysis has failed to identify an alternative diagnosis; however, this "working diagnosis" should be revisited periodically with repeat genetic analysis as genetic/genomic testing improves.
        </p>
        <p class="headingAnchor" id="H2911576192">
         <span class="h2">
          Electroencephalography
         </span>
         <span class="headingEndMark">
          —
         </span>
         EEG may be helpful in the evaluation of RTT, although it is not used for diagnosis. Electroencephalography is always abnormal in RTT and shows characteristic changes. The epileptiform abnormalities typically begin at approximately two years of age [
         <a href="#rid88">
          88
         </a>
         ]. The EEG subsequently deteriorates with loss of expected developmental features and the appearance of abnormal patterns [
         <a href="#rid115">
          115
         </a>
         ]. These include focal, multifocal, and generalized epileptiform abnormalities, and the occurrence of rhythmic slow (theta) activity primarily in the frontal-central regions  (
         <a class="graphic graphic_figure graphicRef111513" href="/z/d/graphic/111513.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
         Evoked potentials typically demonstrate intact peripheral auditory and visual pathways and suggest dysfunction of central or higher cortical pathways. Somatosensory evoked potentials may be characterized by "giant" responses suggesting cortical hyperexcitability.
        </p>
        <p class="headingAnchor" id="H3641044615">
         <span class="h2">
          Staging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prior to the discovery of
         <em>
          MECP2
         </em>
         and subsequent criteria revisions, a staging system was helpful to track the clinical course of RTT [
         <a href="#rid133">
          133
         </a>
         ]. Today it has limited diagnostic utility, but it may be employed as a tool to anticipate potential clinical problems and provide anticipatory guidance to parents and caregivers. However, it is often difficult to discern precisely the transitions between stages. In addition, this system should
         <strong>
          not
         </strong>
         be used to predict life expectancy.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stage I consists of developmental arrest. The onset is between 6 to 18 months, and it may last for many months. During this time there is less eye contact, reduced play, gross motor delays, nonspecific hand wringing, and decelerating head growth  (
         <a class="graphic graphic_picture graphicRef53558" href="/z/d/graphic/53558.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef65333" href="/z/d/graphic/65333.html" rel="external">
          picture 3
         </a>
         ). Infants seem placid and not cuddly compared with healthy infants  (
         <a class="graphic graphic_picture graphicRef76864" href="/z/d/graphic/76864.html" rel="external">
          picture 2
         </a>
         and
         <a class="graphic graphic_picture graphicRef56128" href="/z/d/graphic/56128.html" rel="external">
          picture 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stage II consists of rapid deterioration or regression. The onset is typically between one to four years of age. It may be so acute that parents and caregivers can give a specific date after which their child was no longer normal. In other cases, the onset may be insidious. The duration is usually weeks to months. This phase is characterized by the loss of purposeful hand use and spoken language, and the onset during wakefulness of hand stereotypes and periodic breathing irregularities. Hand stereotypes are most frequently midline and hand wringing or hand washing in character. They occur incessantly during wakefulness but cease during sleep, and continue into adulthood  (
         <a class="graphic graphic_picture graphicRef67899" href="/z/d/graphic/67899.html" rel="external">
          picture 5
         </a>
         ). During this phase, many affected girls exhibit autistic behavior. Variable periods of unprovoked inconsolable crying or irritability and a disturbed sleep pattern are also common  (
         <a class="graphic graphic_picture graphicRef50936" href="/z/d/graphic/50936.html" rel="external">
          picture 6
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stage III begins at 2 to 10 years of age, following the period of rapid deterioration. This phase lasts many years and is characterized by behavioral improvement and some improvement in hand use and communication skills, particularly by using "eye pointing"  (
         <a class="graphic graphic_picture graphicRef64268" href="/z/d/graphic/64268.html" rel="external">
          picture 7
         </a>
         and
         <a class="graphic graphic_picture graphicRef71900" href="/z/d/graphic/71900.html" rel="external">
          picture 8
         </a>
         ). Motor dysfunction  (
         <a class="graphic graphic_picture graphicRef52460" href="/z/d/graphic/52460.html" rel="external">
          picture 9
         </a>
         ) and seizures are more prominent during this time.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stage IV consists of late motor deterioration and usually begins after the age of 10 years. It is characterized by increased rigidity, reduced mobility, dystonia, hypomimia, and bradykinesia  (
         <a class="graphic graphic_picture graphicRef78550" href="/z/d/graphic/78550.html" rel="external">
          picture 10
         </a>
         ). Some girls and women become non-ambulatory  (
         <a class="graphic graphic_picture graphicRef62752" href="/z/d/graphic/62752.html" rel="external">
          picture 11
         </a>
         ) while others continue to ambulate well into adulthood  (
         <a class="graphic graphic_picture graphicRef78909" href="/z/d/graphic/78909.html" rel="external">
          picture 12
         </a>
         ). Cognitive function is stable and interpersonal communication may continue to improve. However, spoken communication is not regained. Seizures also often improve. Quadriparesis, scoliosis, and staring may be features of this stage.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of RTT is based upon clinical and genetic characteristics. (See
         <a class="local">
          'Clinical diagnostic criteria'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3642130387">
         <span class="h2">
          When to suspect RTT
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Typical RTT (see
         <a class="local">
          'Typical RTT'
         </a>
         above) should be suspected in individuals who have apparently normal development in the first 6 to 18 months of life followed by regression of purposeful hand skills and spoken language along with the onset of gait abnormalities and stereotypic hand movements [
         <a href="#rid2">
          2
         </a>
         ]. Postnatal deceleration of head growth should also raise suspicion for RTT, although it does not occur in all individuals with typical RTT.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Atypical RTT (see
         <a class="local">
          'Atypical RTT'
         </a>
         above) may be suspected in individuals who have many but not all of the clinical features of typical RTT [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The diagnosis of typical RTT in middle childhood is usually straightforward because of the distinctive presentation, although a history that confirms a period of regression must be present. However, the diagnosis in early infancy may be more difficult. The diagnosis cannot be made definitively in the young child with decreasing head growth and delayed gross motor skills until she reaches the regression phase with loss of hand skills and spoken language, onset of hand stereotypies, and gait abnormalities. The diagnosis can usually be made in an adult female with intellectual disability and typical signs, including the prominence of motor problems with progression from a hyperkinetic to a bradykinetic state [
         <a href="#rid2">
          2,134,135
         </a>
         ].
        </p>
        <p>
         In various studies, several factors have been associated with a delayed diagnosis of RTT, including normal head size, presentation with less specific features (eg, scoliosis, bone fractures, self-abusive behavior, unusual stereotypic hand movements), age of onset of stereotypies, lack of regression of hand use or verbal language, and impaired acquisition of developmental milestones [
         <a href="#rid51">
          51,136,137
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Clinical diagnostic criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic criteria for RTT  (
         <a class="graphic graphic_table graphicRef111747" href="/z/d/graphic/111747.html" rel="external">
          table 1
         </a>
         ), revised in 2010, are divided into main, exclusionary, and supportive categories [
         <a href="#rid2">
          2
         </a>
         ]. The diagnosis should be considered when postnatal deceleration of head growth is observed, although this feature is not a necessary criterion for RTT.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Main criteria
         </strong>
         for RTT are as follows [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Partial or complete loss of acquired purposeful hand skills
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Partial or complete loss of acquired spoken language
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gait abnormalities: impaired (dyspraxic) or absence of ability
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Stereotypic hand movements such as hand wringing/squeezing, clapping/tapping, mouthing, and washing/rubbing automatisms
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Supportive criteria
         </strong>
         for atypical RTT are the following [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Breathing disturbances when awake
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bruxism when awake
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Impaired sleep pattern
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abnormal muscle tone
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Peripheral vasomotor disturbances
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Scoliosis/kyphosis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Growth retardation
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Small cold hands and feet
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inappropriate laughing/screaming spells
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diminished response to pain
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intense eye communication ("eye pointing")
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Exclusionary criteria
         </strong>
         for typical RTT are as follows [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Brain injury secondary to trauma (peri- or postnatally), neurometabolic disease, or severe infection that causes neurologic problems
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Grossly abnormal psychomotor development in first six months of life
        </p>
        <p>
        </p>
        <p>
         For the diagnosis of
         <strong>
          typical or classic RTT
         </strong>
         , the following are required [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A period of regression followed by recovery or stabilization
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meet all main criteria and no exclusionary criteria
        </p>
        <p>
        </p>
        <p>
         Supportive criteria are not required, although they are frequently present in typical RTT [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         For the clinical diagnosis of
         <strong>
          atypical or variant RTT
         </strong>
         , the following are required [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A period of regression followed by recovery or stabilization
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meet at least 2 of the 4 main criteria
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meet at least 5 of the 11 supportive criteria
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3724851210">
         <span class="h2">
          Genetic confirmation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Careful clinical assessment should be combined with appropriate genetic/genomic analysis. Detection of a pathogenic variant in the
         <em>
          MECP2
         </em>
         gene confirms the diagnosis in patients who fulfill the clinical diagnostic criteria for RTT, but this abnormality is not present in all cases. Pathogenic variants in
         <em>
          MECP2
         </em>
         are found in approximately 95 percent of those with typical RTT and 20 percent of atypical cases [
         <a href="#rid2">
          2
         </a>
         ]. Furthermore,
         <em>
          MECP2
         </em>
         variants have been identified in individuals who lack the clinical features of RTT [
         <a href="#rid2">
          2
         </a>
         ]. Some individuals with an
         <em>
          MECP2
         </em>
         variant who do not fulfill the criteria for either typical or atypical RTT may be classified as having a
         <em>
          MECP2
         </em>
         -related disorder.
        </p>
        <p class="headingAnchor" id="H107356884">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depending upon the age of presentation, the differential diagnosis of typical (classic) RTT includes the following conditions:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autism, hearing/visual disturbance, encephalitis, and metabolic or degenerative disorders such as neuronal ceroid lipofuscinosis, phenylketonuria, and urea cycle disorders. (See
         <a class="medical medical_review" href="/z/d/html/2919.html" rel="external">
          "Overview of phenylketonuria"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2929.html" rel="external">
          "Urea cycle disorders: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/627.html" rel="external">
          "Autism spectrum disorder in children and adolescents: Clinical features", section on 'Terminology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pitt-Hopkins syndrome, which is caused by pathogenic variants in the
         <em>
          TCF4
         </em>
         gene. Characteristic features include distinctive craniofacial abnormalities (that become more apparent with age), developmental delay, intellectual disability, seizures, microcephaly, absent speech, and stereotypic hand movements [
         <a href="#rid138">
          138-140
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Angelman syndrome, which is caused by loss of function of the imprinted
         <em>
          UBE3A
         </em>
         gene [
         <a href="#rid141">
          141,142
         </a>
         ]. Characteristic features include severe intellectual disability, postnatal microcephaly, epilepsy, sleep disturbances, and a movement or balance disorder, usually in the form of gait ataxia and/or tremulous movement of limbs. Common behavior characteristics, alone or in combination, include frequent laughter or smiling, apparent happy demeanor, an easily excitable personality, often with hand flapping movements, and hyperactivity. These manifestations continue into adolescence and adulthood, and additional features include obesity, constipation, scoliosis, limited verbal communication, and self-injurious behavior. (See
         <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">
          "Microdeletion syndromes (chromosomes 12 to 22)", section on '15q11-13 maternal deletion syndrome (Angelman syndrome)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Several developmental disorders (eg, related to
         <em>
          MEF2C
         </em>
         pathogenic variants) may have phenotypic overlap with Rett syndrome that can cause diagnostic confusion in infants and young children [
         <a href="#rid143">
          143,144
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spastic ataxia, cerebral palsy, spinocerebellar degeneration, leukodystrophies, neuroaxonal dystrophy, and Lennox-Gastaut syndrome. (See
         <a class="medical medical_review" href="/z/d/html/6167.html" rel="external">
          "Cerebral palsy: Classification and clinical features"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6169.html" rel="external">
          "Cerebral palsy: Evaluation and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6234.html" rel="external">
          "Overview of the hereditary ataxias"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6230.html" rel="external">
          "Autosomal dominant spinocerebellar ataxias"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6177.html" rel="external">
          "Differential diagnosis of acute central nervous system demyelination in children", section on 'Leukodystrophies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unknown degenerative disorders.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1716162280">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/122569.html" rel="external">
          "Society guideline links: Rett syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H33400376">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathophysiology
         </strong>
         – Rett syndrome (RTT) is a rare neurodevelopmental disorder that occurs almost exclusively in females. In the majority of patients with typical or atypical RTT, the disorder is caused by pathogenic variants in the
         <em>
          MECP2
         </em>
         gene that occur de novo (with a negative family history). Rare patients have atypical RTT caused by pathogenic variants in
         <em>
          CDKL5
         </em>
         or
         <em>
          FOXG1
         </em>
         genes. (See
         <a class="local">
          'Genetics'
         </a>
         above and
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Classification
         </strong>
         – The phenotype of RTT is divided into typical (classic) and atypical (variant forms). (See
         <a class="local">
          'Classification and major features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Classic
         </strong>
         – Patients with classic RTT initially develop normally and then experience loss of speech and purposeful hand use and onset of stereotypic hand movement and gait abnormalities. Deceleration of head growth can be one of the first signs. Additional manifestations can include seizures, autistic features, intermittent breathing abnormalities, autonomic nervous system dysfunction, cardiac abnormalities, and sleep disturbances. (See
         <a class="local">
          'Typical RTT'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Atypical
         </strong>
         – Atypical RTT encompasses variants of RTT that have many but not all of the clinical features of typical RTT. The three defined RTT variants are the preserved speech, early-onset seizure, and congenital variants. (See
         <a class="local">
          'Atypical RTT'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – In the evaluation for suspected RTT, special attention should be paid to the timing of developmental milestones and the presence of a period of regression with loss of hand skills and spoken language. (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of RTT is based upon clinical and genetic characteristics. Diagnostic criteria for typical RTT require a period of regression followed by recovery or stabilization, and fulfillment of all four main criteria (loss of purposeful hand skills, loss of spoken language, gait abnormalities, and stereotypic hand movements) and no exclusionary criteria  (
         <a class="graphic graphic_table graphicRef111747" href="/z/d/graphic/111747.html" rel="external">
          table 1
         </a>
         ). Diagnostic criteria for atypical RTT require a period of regression followed by recovery or stabilization, fulfillment of 2 of the 4 main criteria and 5 of 11 supportive criteria. (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="local">
          'Clinical diagnostic criteria'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Detection of a pathogenic variant in the
         <em>
          MECP2
         </em>
         gene confirms the diagnosis in patients who fulfill the clinical diagnostic criteria for RTT, but this abnormality is not present in all cases.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Depending upon the age of presentation, the differential diagnosis of RTT includes the following (see
         <a class="local">
          'Differential diagnosis'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Autism, hearing/visual disturbance, encephalitis, and metabolic or degenerative disorders
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Spastic ataxia, cerebral palsy, spinocerebellar degeneration, leukodystrophies, neuroaxonal dystrophy, and Lennox-Gastaut syndrome
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pitt-Hopkins syndrome
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Angelman syndrome
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          MEF2C
         </em>
         -related syndromes
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – The treatment of RTT is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/109840.html" rel="external">
          "Rett syndrome: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3271801632">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledges Daniel G Glaze, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Rett A. [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien Med Wochenschr 1966; 116:723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neul JL, Kaufmann WE, Glaze DG, et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010; 68:944.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Percy AK, Lane JB, Childers J, et al. Rett syndrome: North American database. J Child Neurol 2007; 22:1338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neul JL, Fang P, Barrish J, et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 2008; 70:1313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fehr S, Wilson M, Downs J, et al. The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur J Hum Genet 2013; 21:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong LC, Singh S, Wang HP, et al. FOXG1-Related Syndrome: From Clinical to Molecular Genetics and Pathogenic Mechanisms. Int J Mol Sci 2019; 20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Percy AK, Neul JL, Glaze DG, et al. Rett syndrome diagnostic criteria: lessons from the Natural History Study. Ann Neurol 2010; 68:951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trappe R, Laccone F, Cobilanschi J, et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 2001; 68:1093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheadle JP, Gill H, Fleming N, et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 2000; 9:1119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wan M, Lee SS, Zhang X, et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 1999; 65:1520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orrico A, Lam C, Galli L, et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 2000; 481:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meloni I, Bruttini M, Longo I, et al. A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 2000; 67:982.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Villard L, Kpebe A, Cardoso C, et al. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 2000; 55:1188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen RC, Zoghbi HY, Moseley AB, et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992; 51:1229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clayton-Smith J, Watson P, Ramsden S, Black GC. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 2000; 356:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moog U, Van Roozendaal K, Smeets E, et al. MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients. Brain Dev 2006; 28:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castro J, Mellios N, Sur M. Mechanisms and therapeutic challenges in autism spectrum disorders: insights from Rett syndrome. Curr Opin Neurol 2013; 26:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banerjee A, Miller MT, Li K, et al. Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder. Brain 2019; 142:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnston M, Blue ME, Naidu S. Recent advances in understanding synaptic abnormalities in Rett syndrome. F1000Res 2015; 4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohki I, Shimotake N, Fujita N, et al. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 2001; 105:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Díaz de León-Guerrero S, Pedraza-Alva G, Pérez-Martínez L. In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system. Eur J Neurosci 2011; 33:1563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Percy AK. Neuroscience. Path to treat Rett syndrome. Science 2013; 342:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colvin L, Leonard H, de Klerk N, et al. Refining the phenotype of common mutations in Rett syndrome. J Med Genet 2004; 41:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bebbington A, Anderson A, Ravine D, et al. Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology 2008; 70:868.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pidcock FS, Salorio C, Bibat G, et al. Functional outcomes in Rett syndrome. Brain Dev 2016; 38:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Archer H, Evans J, Leonard H, et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J Med Genet 2007; 44:148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuddapah VA, Pillai RB, Shekar KV, et al. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J Med Genet 2014; 51:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown K, Selfridge J, Lagger S, et al. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome. Hum Mol Genet 2016; 25:558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker SA, Chen L, Wilkins AD, et al. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 2013; 152:984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lombardi LM, Baker SA, Zoghbi HY. MECP2 disorders: from the clinic to mice and back. J Clin Invest 2015; 125:2914.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Y, Minassian BA. Will my Rett syndrome patient walk, talk, and use her hands? Neurology 2008; 70:1302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armstrong DD, Dunn JK, Schultz RJ, et al. Organ growth in Rett syndrome: a postmortem examination analysis. Pediatr Neurol 1999; 20:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jellinger K, Armstrong D, Zoghbi HY, Percy AK. Neuropathology of Rett syndrome. Acta Neuropathol 1988; 76:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casanova MF, Naidu S, Goldberg TE, et al. Quantitative magnetic resonance imaging in Rett syndrome. J Neuropsychiatry Clin Neurosci 1991; 3:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reiss AL, Faruque F, Naidu S, et al. Neuroanatomy of Rett syndrome: a volumetric imaging study. Ann Neurol 1993; 34:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armstrong DD. Review of Rett syndrome. J Neuropathol Exp Neurol 1997; 56:843.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bauman ML, Kemper TL, Arin DM. Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 1995; 45:1581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armstrong DD. Neuropathology of Rett syndrome. J Child Neurol 2005; 20:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armstrong D, Dunn JK, Antalffy B, Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 1995; 54:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaufmann WE, Naidu S, Budden S. Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome. Neuropediatrics 1995; 26:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaufmann WE, Taylor CV, Hohmann CF, et al. Abnormalities in neuronal maturation in Rett syndrome neocortex: preliminary molecular correlates. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kozinetz CA, Skender ML, MacNaughton N, et al. Epidemiology of Rett syndrome: a population-based registry. Pediatrics 1993; 91:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bienvenu T, Philippe C, De Roux N, et al. The incidence of Rett syndrome in France. Pediatr Neurol 2006; 34:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagberg B. Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand 1985; 74:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerr AM, Stephenson JB. Rett's syndrome in the west of Scotland. Br Med J (Clin Res Ed) 1985; 291:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leonard H, Bower C, English D. The prevalence and incidence of Rett syndrome in Australia. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagberg B, Witt-Engerström I. Rett syndrome: epidemiology and nosology--progress in knowledge 1986--a conference communication. Brain Dev 1987; 9:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fu C, Armstrong D, Marsh E, et al. Consensus guidelines on managing Rett syndrome across the lifespan. BMJ Paediatr Open 2020; 4:e000717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Einspieler C, Kerr AM, Prechtl HF. Is the early development of girls with Rett disorder really normal? Pediatr Res 2005; 57:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fehr S, Bebbington A, Ellaway C, et al. Altered attainment of developmental milestones influences the age of diagnosis of rett syndrome. J Child Neurol 2011; 26:980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagberg G, Stenbom Y, Witt Engerström I. Head growth in Rett syndrome. Acta Paediatr 2000; 89:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol 1983; 14:471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 2002; 6:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zappella M. The Rett girls with preserved speech. Brain Dev 1992; 14:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Renieri A, Mari F, Mencarelli MA, et al. Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev 2009; 31:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Artuso R, Mencarelli MA, Polli R, et al. Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria. Brain Dev 2010; 32:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scala E, Ariani F, Mari F, et al. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet 2005; 42:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans JC, Archer HL, Colley JP, et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 2005; 13:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bahi-Buisson N, Nectoux J, Rosas-Vargas H, et al. Key clinical features to identify girls with CDKL5 mutations. Brain 2008; 131:2647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russo S, Marchi M, Cogliati F, et al. Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes. Neurogenetics 2009; 10:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leonard H, Downs J, Benke TA, et al. CDKL5 deficiency disorder: clinical features, diagnosis, and management. Lancet Neurol 2022; 21:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Epperson MV, Haws ME, Standridge SM, Gilbert DL. An Atypical Rett Syndrome Phenotype Due to a Novel Missense Mutation in CACNA1A. J Child Neurol 2018; 33:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ariani F, Hayek G, Rondinella D, et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008; 83:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mencarelli MA, Spanhol-Rosseto A, Artuso R, et al. Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet 2010; 47:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Philippe C, Amsallem D, Francannet C, et al. Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females. J Med Genet 2010; 47:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neul JL, Benke TA, Marsh ED, et al. The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. Am J Med Genet B Neuropsychiatr Genet 2019; 180:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reichow B, George-Puskar A, Lutz T, et al. Brief report: systematic review of Rett syndrome in males. J Autism Dev Disord 2015; 45:3377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigafoos J, van der Meer L, Kagohara D, et al. Communication assessment for individuals with Rett syndrome: A systematic review. Res Autism Spectr Disord 2011; 5:692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Temudo T, Oliveira P, Santos M, et al. Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations. Neurology 2007; 68:1183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           FitzGerald PM, Jankovic J, Percy AK. Rett syndrome and associated movement disorders. Mov Disord 1990; 5:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Downs J, Torode I, Wong K, et al. The Natural History of Scoliosis in Females With Rett Syndrome. Spine (Phila Pa 1976) 2016; 41:856.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Killian JT, Lane JB, Lee HS, et al. Scoliosis in Rett Syndrome: Progression, Comorbidities, and Predictors. Pediatr Neurol 2017; 70:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarquinio DC, Motil KJ, Hou W, et al. Growth failure and outcome in Rett syndrome: specific growth references. Neurology 2012; 79:1653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schultz R, Glaze D, Motil K, et al. Hand and foot growth failure in Rett syndrome. J Child Neurol 1998; 13:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leonard H, Ravikumara M, Baikie G, et al. Assessment and management of nutrition and growth in Rett syndrome. J Pediatr Gastroenterol Nutr 2013; 57:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Motil KJ, Schultz RJ, Wong WW, Glaze DG. Increased energy expenditure associated with repetitive involuntary movement does not contribute to growth failure in girls with Rett syndrome. J Pediatr 1998; 132:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Motil KJ, Schultz R, Brown B, et al. Altered energy balance may account for growth failure in Rett syndrome. J Child Neurol 1994; 9:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Motil KJ, Schultz RJ, Kertz B, et al. Increased body protein degradation is associated with lean body mass deficits in girls with Rett syndrome. FASEB J 1999; 13:A9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morton RE, Bonas R, Minford J, et al. Feeding ability in Rett syndrome. Dev Med Child Neurol 1997; 39:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Budden SS. Management of Rett syndrome: a ten year experience. Neuropediatrics 1995; 26:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rice MA, Haas RH. The nutritional aspects of Rett syndrome. J Child Neurol 1988; 3 Suppl:S35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thommessen M, Heiberg A, Kase BF, et al. Feeding problems, height and weight in different groups of disabled children. Acta Paediatr Scand 1991; 80:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thommessen M, Kase BF, Heiberg A. Growth and nutrition in 10 girls with Rett syndrome. Acta Paediatr 1992; 81:686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Motil KJ, Schultz RJ, Browning K, et al. Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr 1999; 29:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Motil KJ, Caeg E, Barrish JO, et al. Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr 2012; 55:292.
          </a>
         </li>
         <li class="breakAll">
          Motil KJ, Schultz RJ, Glaze DG, Armstrong D. Oropharyngeal dysfunction and upper gastrointestinal dysmotility, a reflection of disturbances in the autonomic nervous system in Rett syndrome. In: Rett Disorder and the Developing Brain, Kerr, A, Witt-Engerström, I (Eds), Oxford University Press, Oxford 2001. p.259.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dolce A, Ben-Zeev B, Naidu S, Kossoff EH. Rett syndrome and epilepsy: an update for child neurologists. Pediatr Neurol 2013; 48:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarquinio DC, Hou W, Berg A, et al. Longitudinal course of epilepsy in Rett syndrome and related disorders. Brain 2017; 140:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaze DG, Percy AK, Skinner S, et al. Epilepsy and the natural history of Rett syndrome. Neurology 2010; 74:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steffenburg U, Hagberg G, Hagberg B. Epilepsy in a representative series of Rett syndrome. Acta Paediatr 2001; 90:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaze DG, Frost JD Jr, Zoghbi HY, Percy AK. Rett's syndrome: characterization of respiratory patterns and sleep. Ann Neurol 1987; 21:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerr AM. Early clinical signs in the Rett disorder. Neuropediatrics 1995; 26:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaze DG, Schultz RJ, Frost JD. Rett syndrome: characterization of seizures versus non-seizures. Electroencephalogr Clin Neurophysiol 1998; 106:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haas RH, Dixon SD, Sartoris DJ, Hennessy MJ. Osteopenia in Rett syndrome. J Pediatr 1997; 131:771.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Motil KJ, Ellis KJ, Barrish JO, et al. Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome. Pediatr Res 2008; 64:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jefferson A, Fyfe S, Downs J, et al. Longitudinal bone mineral content and density in Rett syndrome and their contributing factors. Bone 2015; 74:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellis KJ, Shypailo RJ, Hardin DS, et al. Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res 2001; 16:1658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leonard H, Thomson MR, Glasson EJ, et al. A population-based approach to the investigation of osteopenia in Rett syndrome. Dev Med Child Neurol 1999; 41:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Downs J, Bebbington A, Woodhead H, et al. Early determinants of fractures in Rett syndrome. Pediatrics 2008; 121:540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerr AM, Armstrong DD, Prescott RJ, et al. Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sekul EA, Moak JP, Schultz RJ, et al. Electrocardiographic findings in Rett syndrome: an explanation for sudden death? J Pediatr 1994; 125:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Driscoll DJ, Edwards WD. Sudden unexpected death in children and adolescents. J Am Coll Cardiol 1985; 5:118B.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Acampa M, Guideri F. Cardiac disease and Rett syndrome. Arch Dis Child 2006; 91:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guideri F, Acampa M, Hayek G, et al. Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death. Neuropediatrics 1999; 30:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellaway CJ, Sholler G, Leonard H, Christodoulou J. Prolonged QT interval in Rett syndrome. Arch Dis Child 1999; 80:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuster-Siebert M, Castro-Gago M. Electrocardiographic findings in Rett syndrome. J Pediatr 1995; 126:506.
          </a>
         </li>
         <li class="breakAll">
          Julu POO. The Central Autonomic Disturbance in Rett Syndrome. In: Rett Disorder and the Developing Brain, Kerr A, Witt-Engerström I (Eds), Oxford University Press, Oxford 2001. p.131.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weese-Mayer DE, Lieske SP, Boothby CM, et al. Autonomic dysregulation in young girls with Rett Syndrome during nighttime in-home recordings. Pediatr Pulmonol 2008; 43:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deguchi K, Antalffy BA, Twohill LJ, et al. Substance P immunoreactivity in Rett syndrome. Pediatr Neurol 2000; 22:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsuishi T, Nagamitsu S, Yamashita Y, et al. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome. Ann Neurol 1997; 42:978.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smeets EE, Pelc K, Dan B. Rett Syndrome. Mol Syndromol 2012; 2:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaze DG. Neurophysiology of Rett syndrome. J Child Neurol 2005; 20:740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pini G, Bigoni S, Congiu L, et al. Rett syndrome: a wide clinical and autonomic picture. Orphanet J Rare Dis 2016; 11:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaze DG, Frost JD Jr, Zoghbi HY, Percy AK. Rett's syndrome. Correlation of electroencephalographic characteristics with clinical staging. Arch Neurol 1987; 44:1053.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Southall DP, Kerr AM, Tirosh E, et al. Hyperventilation in the awake state: potentially treatable component of Rett syndrome. Arch Dis Child 1988; 63:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cirignotta F, Lugaresi E, Montagna P. Breathing impairment in Rett syndrome. Am J Med Genet Suppl 1986; 1:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marcus CL, Carroll JL, McColley SA, et al. Polysomnographic characteristics of patients with Rett syndrome. J Pediatr 1994; 125:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katz DM, Dutschmann M, Ramirez JM, Hilaire G. Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 2009; 168:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarquinio DC, Hou W, Neul JL, et al. The course of awake breathing disturbances across the lifespan in Rett syndrome. Brain Dev 2018; 40:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ogier M, Katz DM. Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network. Respir Physiol Neurobiol 2008; 164:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramirez JM, Ward CS, Neul JL. Breathing challenges in Rett syndrome: lessons learned from humans and animal models. Respir Physiol Neurobiol 2013; 189:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rohdin M, Fernell E, Eriksson M, et al. Disturbances in cardiorespiratory function during day and night in Rett syndrome. Pediatr Neurol 2007; 37:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Felice C, Guazzi G, Rossi M, et al. Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study. Chest 2010; 138:386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young D, Nagarajan L, de Klerk N, et al. Sleep problems in Rett syndrome. Brain Dev 2007; 29:609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boban S, Wong K, Epstein A, et al. Determinants of sleep disturbances in Rett syndrome: Novel findings in relation to genotype. Am J Med Genet A 2016; 170:2292.
          </a>
         </li>
         <li class="breakAll">
          Christodoulou J, Ho G. MECP2-related disorders. GeneReviews. http://www.ncbi.nlm.nih.gov/books/NBK1497/ (Accessed on September 09, 2015).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giesbers S, Didden R, Radstaake M, et al. Incontinence in Individuals with Rett Syndrome: A Comparative Study. J Dev Phys Disabil 2012; 24:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Percy AK, Lane JB. Rett syndrome: model of neurodevelopmental disorders. J Child Neurol 2005; 20:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gold WA, Christodoulou J. The Utility of Next-Generation Sequencing in Gene Discovery for Mutation-Negative Patients with Rett Syndrome. Front Cell Neurosci 2015; 9:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucariello M, Vidal E, Vidal S, et al. Whole exome sequencing of Rett syndrome-like patients reveals the mutational diversity of the clinical phenotype. Hum Genet 2016; 135:1343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Srivastava S, Desai S, Cohen J, et al. Monogenic disorders that mimic the phenotype of Rett syndrome. Neurogenetics 2018; 19:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagberg B, Witt-Engerström I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet Suppl 1986; 1:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagberg BA, Skjeldal OH. Rett variants: a suggested model for inclusion criteria. Pediatr Neurol 1994; 11:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           FitzGerald PM, Jankovic J, Glaze DG, et al. Extrapyramidal involvement in Rett's syndrome. Neurology 1990; 40:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarquinio DC, Hou W, Neul JL, et al. Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosis. Pediatr Neurol 2015; 52:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fehr S, Downs J, Bebbington A, Leonard H. Atypical presentations and specific genotypes are associated with a delay in diagnosis in females with Rett syndrome. Am J Med Genet A 2010; 152A:2535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marangi G, Zollino M. Pitt-Hopkins Syndrome and Differential Diagnosis: A Molecular and Clinical Challenge. J Pediatr Genet 2015; 4:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peippo M, Ignatius J. Pitt-Hopkins Syndrome. Mol Syndromol 2012; 2:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodspeed K, Newsom C, Morris MA, et al. Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series. J Child Neurol 2018; 33:233.
          </a>
         </li>
         <li class="breakAll">
          Dagli AI, Mueller J, Williams CA. Angelman syndrome. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK1144/ (Accessed on September 16, 2016).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buiting K, Williams C, Horsthemke B. Angelman syndrome - insights into a rare neurogenetic disorder. Nat Rev Neurol 2016; 12:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambert L, Bienvenu T, Allou L, et al. MEF2C mutations are a rare cause of Rett or severe Rett-like encephalopathies. Clin Genet 2012; 82:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allou L, Julia S, Amsallem D, et al. Rett-like phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5-related disease. Clin Genet 2017; 91:431.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6178 Version 40.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5300597" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : [On a unusual brain atrophy syndrome in hyperammonemia in childhood].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21154482" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Rett syndrome: revised diagnostic criteria and nomenclature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10508514" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18174548" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Rett syndrome: North American database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18337588" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22872100" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31454984" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : FOXG1-Related Syndrome: From Clinical to Molecular Genetics and Pathogenic Mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21104896" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Rett syndrome diagnostic criteria: lessons from the Natural History Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11309679" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10767337" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10577905" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11007980" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : MECP2 mutation in male patients with non-specific X-linked mental retardation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10986043" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11071498" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Two affected boys in a Rett syndrome family: clinical and molecular findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1281384" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11022934" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16376510" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23449173" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Mechanisms and therapeutic challenges in autism spectrum disorders: insights from Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30649225" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26918155" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Recent advances in understanding synaptic abnormalities in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11371345" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21453447" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24136956" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Neuroscience. Path to treat Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14729826" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Refining the phenotype of common mutations in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18332345" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Investigating genotype-phenotype relationships in Rett syndrome using an international data set.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26175308" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Functional outcomes in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16905679" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24399845" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26647311" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23452848" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26237041" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : MECP2 disorders: from the clinic to mice and back.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18413585" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Will my Rett syndrome patient walk, talk, and use her hands?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10082341" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Organ growth in Rett syndrome: a postmortem examination analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2900587" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Neuropathology of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7580176" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Quantitative magnetic resonance imaging in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8338347" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Neuroanatomy of Rett syndrome: a volumetric imaging study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9258253" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Review of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7644058" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16225830" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Neuropathology of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7876888" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Selective dendritic alterations in the cortex of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7566447" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9452926" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Abnormalities in neuronal maturation in Rett syndrome neocortex: preliminary molecular correlates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8424025" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Epidemiology of Rett syndrome: a population-based registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16647997" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : The incidence of Rett syndrome in France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4003065" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2412628" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Rett's syndrome in the west of Scotland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9452912" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The prevalence and incidence of Rett syndrome in Australia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3324795" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Rett syndrome: epidemiology and nosology--progress in knowledge 1986--a conference communication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32984552" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Consensus guidelines on managing Rett syndrome across the lifespan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15718369" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Is the early development of girls with Rett disorder really normal?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21543746" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Altered attainment of developmental milestones influences the age of diagnosis of rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10709891" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Head growth in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6638958" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12378695" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1621933" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The Rett girls with preserved speech.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18562141" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19362436" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15689447" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16015284" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Early onset seizures and Rett-like features associated with mutations in CDKL5.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18790821" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Key clinical features to identify girls with CDKL5 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19241098" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35483386" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : CDKL5 deficiency disorder: clinical features, diagnosis, and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29366381" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : An Atypical Rett Syndrome Phenotype Due to a Novel Missense Mutation in CACNA1A.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18571142" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : FOXG1 is responsible for the congenital variant of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19578037" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Novel FOXG1 mutations associated with the congenital variant of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19564653" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30536762" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26254891" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Brief report: systematic review of Rett syndrome in males.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Communication assessment for individuals with Rett syndrome: A systematic review
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17420401" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2388636" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Rett syndrome and associated movement disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26679887" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The Natural History of Scoliosis in Females With Rett Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28347601" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Scoliosis in Rett Syndrome: Progression, Comorbidities, and Predictors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23035069" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Growth failure and outcome in Rett syndrome: specific growth references.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9512306" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Hand and foot growth failure in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24084372" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Assessment and management of nutrition and growth in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9506632" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Increased energy expenditure associated with repetitive involuntary movement does not contribute to growth failure in girls with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7930413" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Altered energy balance may account for growth failure in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Increased body protein degradation is associated with lean body mass deficits in girls with Rett syndrome
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9236700" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Feeding ability in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7566457" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Management of Rett syndrome: a ten year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3198901" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : The nutritional aspects of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1831317" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Feeding problems, height and weight in different groups of disabled children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1421909" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Growth and nutrition in 10 girls with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10400100" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22331013" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22331013" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23583050" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Rett syndrome and epilepsy: an update for child neurologists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28007990" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Longitudinal course of epilepsy in Rett syndrome and related disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20231667" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Epilepsy and the natural history of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11227330" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Epilepsy in a representative series of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3579223" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Rett's syndrome: characterization of respiratory patterns and sleep.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7566455" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Early clinical signs in the Rett disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9680167" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Rett syndrome: characterization of seizures versus non-seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9403666" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Osteopenia in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18535484" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25659951" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Longitudinal bone mineral content and density in Rett syndrome and their contributing factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11547835" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Z score prediction model for assessment of bone mineral content in pediatric diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10378758" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : A population-based approach to the investigation of osteopenia in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18310203" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Early determinants of fractures in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9452925" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Rett syndrome: analysis of deaths in the British survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8021793" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Electrocardiographic findings in Rett syndrome: an explanation for sudden death?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3998328" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Sudden unexpected death in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16632674" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Cardiac disease and Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10480210" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10208957" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Prolonged QT interval in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7869219" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Electrocardiographic findings in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7869219" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Electrocardiographic findings in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18831533" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Autonomic dysregulation in young girls with Rett Syndrome during nighttime in-home recordings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10788742" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Substance P immunoreactivity in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9403492" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22670134" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Rett Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16225829" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Neurophysiology of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27682832" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Rett syndrome: a wide clinical and autonomic picture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3632378" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Rett's syndrome. Correlation of electroencephalographic characteristics with clinical staging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3140736" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Hyperventilation in the awake state: potentially treatable component of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3087178" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Breathing impairment in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8040765" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Polysomnographic characteristics of patients with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19394452" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29657083" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : The course of awake breathing disturbances across the lifespan in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18534925" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23816600" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Breathing challenges in Rett syndrome: lessons learned from humans and animal models.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17950419" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Disturbances in cardiorespiratory function during day and night in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20348192" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17531413" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Sleep problems in Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27255190" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Determinants of sleep disturbances in Rett syndrome: Novel findings in relation to genotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27255190" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Determinants of sleep disturbances in Rett syndrome: Novel findings in relation to genotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22639525" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Incontinence in Individuals with Rett Syndrome: A Comparative Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16225824" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Rett syndrome: model of neurodevelopmental disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26236194" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : The Utility of Next-Generation Sequencing in Gene Discovery for Mutation-Negative Patients with Rett Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27541642" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Whole exome sequencing of Rett syndrome-like patients reveals the mutational diversity of the clinical phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29322350" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Monogenic disorders that mimic the phenotype of Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3087203" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7986294" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Rett variants: a suggested model for inclusion criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2073236" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Extrapyramidal involvement in Rett's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25801175" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20815036" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Atypical presentations and specific genotypes are associated with a delay in diagnosis in females with Rett syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27617128" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Pitt-Hopkins Syndrome and Differential Diagnosis: A Molecular and Clinical Challenge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22670138" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Pitt-Hopkins Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29318938" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29318938" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27615419" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Angelman syndrome - insights into a rare neurogenetic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22449245" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : MEF2C mutations are a rare cause of Rett or severe Rett-like encephalopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27062609" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Rett-like phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5-related disease.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
